Strategic Financial Group LLC cut its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 3.0% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,871 shares of the pharmacy operator’s stock after selling 499 shares during the period. Strategic Financial Group LLC’s holdings in Walgreens Boots Alliance were worth $1,005,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Massey Quick Simon & CO. LLC acquired a new position in Walgreens Boots Alliance in the fourth quarter valued at $27,000. Horan Capital Advisors LLC. acquired a new position in Walgreens Boots Alliance in the first quarter valued at $25,000. Cornerstone Advisors Inc. increased its stake in Walgreens Boots Alliance by 102.4% in the third quarter. Cornerstone Advisors Inc. now owns 423 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 214 shares during the period. Murphy Pohlad Asset Management LLC acquired a new position in Walgreens Boots Alliance in the fourth quarter valued at $29,000. Finally, PRW Wealth Management LLC acquired a new position in Walgreens Boots Alliance in the fourth quarter valued at $34,000. 64.77% of the stock is owned by hedge funds and other institutional investors.
WBA has been the topic of a number of recent research reports. BidaskClub lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Wednesday, March 6th. UBS Group dropped their price target on shares of Walgreens Boots Alliance from $70.00 to $65.00 and set a “sell” rating on the stock in a research note on Monday, March 4th. Morgan Stanley set a $61.00 price target on shares of Walgreens Boots Alliance and gave the stock a “hold” rating in a research note on Tuesday, May 14th. Cowen reiterated a “hold” rating and set a $66.00 price target on shares of Walgreens Boots Alliance in a research note on Sunday, March 31st. Finally, Barclays dropped their price target on shares of Walgreens Boots Alliance from $78.00 to $60.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 3rd. Five research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $68.00.
In related news, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the company’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $53.05, for a total transaction of $1,061,000.00. Following the completion of the transaction, the chief accounting officer now owns 435,811 shares of the company’s stock, valued at $23,119,773.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Ornella Barra acquired 18,000 shares of the company’s stock in a transaction dated Wednesday, April 3rd. The stock was acquired at an average cost of $54.56 per share, with a total value of $982,080.00. Following the transaction, the chief operating officer now directly owns 26,425 shares of the company’s stock, valued at $1,441,748. The disclosure for this purchase can be found here. Corporate insiders own 15.73% of the company’s stock.
WBA traded up $0.18 on Wednesday, hitting $52.94. 2,928,450 shares of the company were exchanged, compared to its average volume of 6,516,903. The company has a current ratio of 0.78, a quick ratio of 0.38 and a debt-to-equity ratio of 0.50. Walgreens Boots Alliance Inc has a fifty-two week low of $51.79 and a fifty-two week high of $86.31. The firm has a market capitalization of $48.40 billion, a P/E ratio of 8.79, a PEG ratio of 1.06 and a beta of 0.77.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Tuesday, April 2nd. The pharmacy operator reported $1.64 earnings per share for the quarter, missing the consensus estimate of $1.70 by ($0.06). Walgreens Boots Alliance had a return on equity of 22.00% and a net margin of 3.77%. The company had revenue of $34.53 billion for the quarter, compared to analyst estimates of $34.57 billion. During the same quarter in the previous year, the company posted $1.73 earnings per share. The company’s quarterly revenue was up 4.6% compared to the same quarter last year. Analysts predict that Walgreens Boots Alliance Inc will post 5.99 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Shareholders of record on Monday, May 20th will be given a dividend of $0.44 per share. The ex-dividend date is Friday, May 17th. This represents a $1.76 annualized dividend and a yield of 3.32%. Walgreens Boots Alliance’s payout ratio is currently 29.24%.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Recommended Story: P/E Growth (PEG)
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.